TA-65 and Aging Associated Microvascular Dysfunction

NANot yet recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Telomere ShorteningAgingVascular Diseases
Interventions
DIETARY_SUPPLEMENT

TA-65

TA-65 is a purified small molecule extracted from Astragalus root

OTHER

Placebo

Inactive formulation

All Listed Sponsors
collaborator

University of Louisville

OTHER

collaborator

Penn State University

OTHER

lead

Medical College of Wisconsin

OTHER

NCT05598359 - TA-65 and Aging Associated Microvascular Dysfunction | Biotech Hunter | Biotech Hunter